Benefits of β-Blocker Therapy for Heart Failure | Zendy

Sidney Goldstein | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Benefits of β-Blocker Therapy for Heart Failure

Author(s) -

Sidney Goldstein

Publication year - 2002

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.162.6.641

Subject(s) - heart failure , medicine , clinical trial , intensive care medicine , beta (programming language) , adrenergic beta antagonists , cardiology , pharmacology , propranolol , computer science , programming language

Our understanding of factors contributing to the progression of heart failure has advanced dramatically over the past 2 decades. We have also gained considerable insight into the pharmacology of beta-adrenergic receptor blockers (beta-blockers). Based on this knowledge, we can now appreciate the potential of these drugs for the treatment of heart failure. Several beta-blockers have been shown to be clinically effective in the treatment of heart failure. Critical evaluation of the evidence from basic research studies, as well as clinical trials in patients with heart failure, helps to delineate the theoretical and clinical benefits of beta-blockers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research